\contentsline {section}{\numberline {1}Introduzione}{2}%
\contentsline {subsection}{\numberline {1.1}Lessico e nozioni di base}{2}%
\contentsline {paragraph}{Varianti Causali}{2}%
\contentsline {paragraph}{Trait-Associated Loci}{2}%
\contentsline {paragraph}{QTL}{2}%
\contentsline {paragraph}{GWAS}{2}%
\contentsline {paragraph}{Lead Variant}{2}%
\contentsline {paragraph}{P-Value}{2}%
\contentsline {paragraph}{Tag Variants}{2}%
\contentsline {paragraph}{Linkage Disequilibrium}{2}%
\contentsline {paragraph}{Fine Mapping}{2}%
\contentsline {paragraph}{Single Evidence Score}{2}%
\contentsline {paragraph}{Proxy}{2}%
\contentsline {section}{\numberline {2}Open Targets Genetics}{2}%
\contentsline {subsection}{\numberline {2.1}Cos'Ã¨ Open Target Genetics?}{2}%
\contentsline {subsection}{\numberline {2.2}L'Obiettivo}{3}%
\contentsline {subsection}{\numberline {2.3}Il Metodo}{3}%
\contentsline {section}{\numberline {3}Come funziona?}{4}%
\contentsline {section}{\numberline {4}Pipeline}{4}%
\contentsline {subsection}{\numberline {4.1}Assigning Variants to Genes (V2G)}{4}%
\contentsline {subsection}{\numberline {4.2}Assigning Variants to Disease (V2D)}{4}%
\contentsline {subsection}{\numberline {4.3}Prioritising causal genes at GWAS loci (L2G)}{5}%
\contentsline {section}{\numberline {5}Un esempio di utilizzo}{5}%
\contentsline {subsection}{\numberline {5.1}Study}{5}%
\contentsline {subsubsection}{\numberline {5.1.1}Compare Studies}{6}%
\contentsline {subsection}{\numberline {5.2}Variant}{8}%
\contentsline {subsection}{\numberline {5.3}Gene}{10}%
\contentsline {subsubsection}{\numberline {5.3.1}Gene Priorisation}{11}%
\contentsline {section}{\numberline {6}Possibili domande}{12}%
